Washington, February 10
Coffee lovers, rejoice! The new three large, well-known heart disease studies circulated by the American Heart Association suggest that drinking one or more cups of caffeinate
1,300 prostate tumor samples studied Immunotherapy-based precision medicine clinical trials being developed
CHICAGO - Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of a surprising type of immune cell in the tumor. The findings could lead to immune-based precision medicine treatment for men of all races with localized aggressive and advanced prostate cancer.
In the new study, Northwestern scientists showed tumors from Black men and men of African ancestry have an increased proportion of a special immune cell called plasma cells compared to the tumors of white men. A research team lead by Dr. Edward Schaeffer, chair of urology at Northwestern University Feinberg School of Medicine and Northwestern Medicine, found this increase in plasma cells correlated with improved cancer survival following surgery and identify plas
Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.